JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways

Signaling Pathways

A8455 Nilvadipine

Summary: Calcium channel inhibitor

insoluble in H2O; ≥12.4 mg/mL
A8456 JTC-801

Target: NOP Receptors

Summary: KOR-3 (NOP) receptor antagonist

≥22.4 mg/mL
A8458 Lamivudine

Target: HBV Proteases

Summary: Nucleoside analog reverse transcriptase inhibitor

≥10.5 mg/mL
A8459 Laquinimod (ABR-215062)

Summary: Immunomodulator,orally-available,quinolinone-based and broad spectrum

insoluble in H2O; ≥17.25 mg/mL
A8460 Levodopa

Summary: Dopamine precursor.

insoluble in DMSO; insoluble in EtOH; ≥6.57 mg/mL
A8461 L-Glutamine

Summary: Non-essential amino acid

insoluble in EtOH; insoluble in DMSO; ≥6.2 mg/mL
A8462 Lithium Citrate

Summary: Mood stabilizer

insoluble in EtOH; ≥14.1 mg/mL
A8463 Lithocholic Acid

Target: Farnesoid X receptors (FXRs)|Vitamin D receptors (VDRs)|Pregnane X receptor(PXR)

Summary: Toxic secondary bile acid; induces intrahepatic cholestasis; FXR antagonist and PXR/SXR agonist

insoluble in H2O; ≥12.95 mg/mL
A8464 LY2109761
4 Citation

Summary: TβRI/II kinase inhibitor

≥22.1 mg/mL
A8466 Meloxicam (Mobic)

Target: COX

Summary: Nonsteroidal anti-inflammatory drug

insoluble in H2O; insoluble in EtOH; ≥17.57 mg/mL